In these cancers, MiR-7 targets several proto-oncogenes, such as insulin receptor substrate 1 (IRS1), epidermal growth factor receptor (EGFR), and p21 protein (Cdc42/Rac)-activated kinase 1 (PAK1) [10, 11]. Here, EGFR is linked to cancer.